Annual CFI
$41.50 M
+$82.08 M+202.27%
December 31, 2023
Summary
- As of February 7, 2025, VINC annual cash flow from investing activities is $41.50 million, with the most recent change of +$82.08 million (+202.27%) on December 31, 2023.
- During the last 3 years, VINC annual CFI has risen by +$41.50 million (+100.00%).
- VINC annual CFI is now at all-time high.
Performance
VINC Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$1.37 M
+$9.71 M+116.48%
September 30, 2024
Summary
- As of February 7, 2025, VINC quarterly cash flow from investing activities is $1.37 million, with the most recent change of +$9.71 million (+116.48%) on September 30, 2024.
- Over the past year, VINC quarterly CFI has dropped by -$4.38 million (-76.10%).
- VINC quarterly CFI is now -90.88% below its all-time high of $15.06 million, reached on September 30, 2023.
Performance
VINC Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$1.21 M
-$13.69 M-109.72%
September 30, 2024
Summary
- As of February 7, 2025, VINC TTM cash flow from investing activities is -$1.21 million, with the most recent change of -$13.69 million (-109.72%) on September 30, 2024.
- Over the past year, VINC TTM CFI has dropped by -$42.71 million (-102.92%).
- VINC TTM CFI is now -102.92% below its all-time high of $41.50 million, reached on December 31, 2023.
Performance
VINC TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
VINC Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +202.3% | -76.1% | -102.9% |
| 3 y3 years | +100.0% | +100.0% | -370.2% |
| 5 y5 years | - | - | - |
VINC Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +202.3% | -90.9% | +106.7% | -102.9% | +97.0% |
| 5 y | 5-year | at high | +202.3% | -90.9% | +106.7% | -102.9% | +97.0% |
| alltime | all time | at high | +202.3% | -90.9% | +106.7% | -102.9% | +97.0% |
Vincerx Pharma Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.37 M(-116.5%) | -$1.21 M(-109.7%) |
| Jun 2024 | - | -$8.34 M(<-9900.0%) | $12.47 M(-65.0%) |
| Mar 2024 | - | $0.00(-100.0%) | $35.62 M(-14.2%) |
| Dec 2023 | $41.50 M(-202.3%) | $5.75 M(-61.8%) | $41.50 M(+170.1%) |
| Sep 2023 | - | $15.06 M(+1.7%) | $15.37 M(-177.3%) |
| Jun 2023 | - | $14.80 M(+151.6%) | -$19.89 M(-42.7%) |
| Mar 2023 | - | $5.88 M(-128.9%) | -$34.69 M(-14.5%) |
| Dec 2022 | -$40.58 M | -$20.38 M(+0.9%) | -$40.58 M(+100.9%) |
| Sep 2022 | - | -$20.20 M(<-9900.0%) | -$20.20 M(>+9900.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $0.00(0.0%) | -$30.00 K(-88.4%) |
| Mar 2022 | - | $0.00(-100.0%) | -$258.00 K(-95.1%) |
| Dec 2021 | -$5.26 M(<-9900.0%) | -$8000.00(-63.6%) | -$5.26 M(+0.2%) |
| Sep 2021 | - | -$22.00 K(-90.4%) | -$5.25 M(+0.4%) |
| Jun 2021 | - | -$228.00 K(-95.4%) | -$5.23 M(+4.6%) |
| Mar 2021 | - | -$5.00 M(<-9900.0%) | -$5.00 M(<-9900.0%) |
| Dec 2020 | $0.00 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2020 | - | $0.00 | $0.00 |
FAQ
- What is Vincerx Pharma annual cash flow from investing activities?
- What is the all time high annual CFI for Vincerx Pharma?
- What is Vincerx Pharma annual CFI year-on-year change?
- What is Vincerx Pharma quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Vincerx Pharma?
- What is Vincerx Pharma quarterly CFI year-on-year change?
- What is Vincerx Pharma TTM cash flow from investing activities?
- What is the all time high TTM CFI for Vincerx Pharma?
- What is Vincerx Pharma TTM CFI year-on-year change?
What is Vincerx Pharma annual cash flow from investing activities?
The current annual CFI of VINC is $41.50 M
What is the all time high annual CFI for Vincerx Pharma?
Vincerx Pharma all-time high annual cash flow from investing activities is $41.50 M
What is Vincerx Pharma annual CFI year-on-year change?
Over the past year, VINC annual cash flow from investing activities has changed by +$82.08 M (+202.27%)
What is Vincerx Pharma quarterly cash flow from investing activities?
The current quarterly CFI of VINC is $1.37 M
What is the all time high quarterly CFI for Vincerx Pharma?
Vincerx Pharma all-time high quarterly cash flow from investing activities is $15.06 M
What is Vincerx Pharma quarterly CFI year-on-year change?
Over the past year, VINC quarterly cash flow from investing activities has changed by -$4.38 M (-76.10%)
What is Vincerx Pharma TTM cash flow from investing activities?
The current TTM CFI of VINC is -$1.21 M
What is the all time high TTM CFI for Vincerx Pharma?
Vincerx Pharma all-time high TTM cash flow from investing activities is $41.50 M
What is Vincerx Pharma TTM CFI year-on-year change?
Over the past year, VINC TTM cash flow from investing activities has changed by -$42.71 M (-102.92%)